Naohiko Takahashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Naohiko Takahashi has a total of 375 co-authors. Here are the top co-authors by number of shared publications:
- Hidekazu Kondo
Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University , 1-1 Idaigaoka, Hasama, Yufu City, Oita 879-5593
18 shared publications Tetsuji Shinohara
Department of Cardiology and Clinical Examination Faculty of Medicine, Oita University Oita Japan
10 shared publicationsYasushi Teshima
Department of Cardiology and Clinical Examination, Faculty of Medicine Oita University Oita Japan
10 shared publicationsAkira Fukui
Department of Cardiology and Clinical Examination, Oita University Faculty of Medicine, Oita, Japan
9 shared publicationsMikiko Nakagawa
Medical Education Center, Oita University Faculty of Medicine, Oita, Japan
8 shared publicationsHidefumi Akioka
Department of Cardiology and Clinical Examination, Faculty of Medicine Oita University Oita Japan
7 shared publications
Latest Publications
- 1 September 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (17)
Histological Determinants of Atrial Dysfunction in Patients With Atrial Fibrillation
Background: Atrial fibrillation (AF) is associated with diverse histological abnormalities, but their contributions to atrial dysfunction and functional recovery remain unclear. Methods: In a discovery cohort of 375 patients with nonvalvular AF undergoing catheter ablation, atrial biopsy samples were quantitatively analyzed for fibrosis, intercellular space expansion, myofibrillar loss, myocardial nuclear density, and amyloid deposition. Left atrial reservoir strain (LASr) was assessed as a measure of atrial function during sinus rhythm (Group 1) or AF (Group 2) at the time of echocardiography. Functional recovery was defined as the change in LASr 12 months after ablation. Findings were validated in an independent cohort of 191 patients with AF. A subset of samples was additionally analyzed for DNA damage markers, poly(ADP‐ribose), and phosphorylated histone H2A.X. Results: LASr improved significantly after ablation in Group 2 but not in Group 1. Multivariable analyses identified greater fibrosis, reduced myocardial nuclear density, and advanced amyloid deposition as significant determinants of impaired atrial function in both groups and of limited postablation functional recovery in Group 2 (all P <0.01). Amyloid deposition was also significantly associated with adverse clinical outcomes. Decision‐tree models incorporating LASr accurately identified advanced amyloid deposition in both cohorts (accuracy, 94%–96%). DNA damage markers were inversely associated with myocardial nuclear density and positively associated with cardiomyocyte hypertrophy. Conclusions: Fibrosis, DNA damage–associated reduction in myocardial nuclear density, and advanced atrial amyloidosis are key determinants of atrial dysfunction and impaired postablation functional recovery in patients with AF. LASr enables noninvasive identification of advanced atrial amyloidosis.
- 1 September 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (17)
Histological Determinants of Atrial Dysfunction in Patients With Atrial Fibrillation
Background: Atrial fibrillation (AF) is associated with diverse histological abnormalities, but their contributions to atrial dysfunction and functional recovery remain unclear. Methods: In a discovery cohort of 375 patients with nonvalvular AF undergoing catheter ablation, atrial biopsy samples were quantitatively analyzed for fibrosis, intercellular space expansion, myofibrillar loss, myocardial nuclear density, and amyloid deposition. Left atrial reservoir strain (LASr) was assessed as a measure of atrial function during sinus rhythm (Group 1) or AF (Group 2) at the time of echocardiography. Functional recovery was defined as the change in LASr 12 months after ablation. Findings were validated in an independent cohort of 191 patients with AF. A subset of samples was additionally analyzed for DNA damage markers, poly(ADP‐ribose), and phosphorylated histone H2A.X. Results: LASr improved significantly after ablation in Group 2 but not in Group 1. Multivariable analyses identified greater fibrosis, reduced myocardial nuclear density, and advanced amyloid deposition as significant determinants of impaired atrial function in both groups and of limited postablation functional recovery in Group 2 (all P <0.01). Amyloid deposition was also significantly associated with adverse clinical outcomes. Decision‐tree models incorporating LASr accurately identified advanced amyloid deposition in both cohorts (accuracy, 94%–96%). DNA damage markers were inversely associated with myocardial nuclear density and positively associated with cardiomyocyte hypertrophy. Conclusions: Fibrosis, DNA damage–associated reduction in myocardial nuclear density, and advanced atrial amyloidosis are key determinants of atrial dysfunction and impaired postablation functional recovery in patients with AF. LASr enables noninvasive identification of advanced atrial amyloidosis.
- Open Access
- 28 August 2026
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 31 (5)
Electrocardiographic Predictors of Early Recurrence of Atrial Fibrillation After Electrical Cardioversion
Background: Although electrical cardioversion (ECV) effectively restores sinus rhythm in patients with persistent atrial fibrillation (AF), early recurrence after successful ECV remains common in clinical practice. We investigated whether simple 12‐lead electrocardiographic markers and a composite ECG score could predict early AF recurrence. Methods: We retrospectively analyzed 195 patients with persistent AF who underwent successful ECV. Electrocardiograms recorded immediately after ECV were evaluated for notched P‐wave, fragmented QRS (fQRS), and early repolarization pattern (ERP). The ECG composite score was defined as the sum of these markers (0–3). Early AF recurrence was defined as electrocardiographically documented recurrence within 10 days after ECV. Multivariable logistic regression analysis was performed. Results: Early AF recurrence occurred in 100 patients (51.3%). AF duration was longer in patients with recurrence (12 [3–57] vs. 5 [2–15] months, p < 0.001). Notched P‐wave (76.0% vs. 24.2%, p < 0.001), fQRS (74.0% vs. 57.9%, p = 0.017), and ERP (41.0% vs. 24.2%, p = 0.015) were more frequent in patients with recurrence. In multivariable analysis, notched P‐wave (OR 11.80), fQRS (OR 2.34), and ERP (OR 3.54) independently predicted recurrence (all p < 0.05). The ECG composite score was also independently associated with recurrence (OR 4.91 per 1‐point increase, p < 0.001), with a stepwise increase in recurrence across score categories. Conclusions: Simple 12‐lead ECG markers and a composite ECG score may help predict early AF recurrence and guide rhythm‐control strategies after ECV in patients with persistent AF.
- 28 August 2026
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 31 (5)
Open AccessElectrocardiographic Predictors of Early Recurrence of Atrial Fibrillation After Electrical Cardioversion
Background: Although electrical cardioversion (ECV) effectively restores sinus rhythm in patients with persistent atrial fibrillation (AF), early recurrence after successful ECV remains common in clinical practice. We investigated whether simple 12‐lead electrocardiographic markers and a composite ECG score could predict early AF recurrence. Methods: We retrospectively analyzed 195 patients with persistent AF who underwent successful ECV. Electrocardiograms recorded immediately after ECV were evaluated for notched P‐wave, fragmented QRS (fQRS), and early repolarization pattern (ERP). The ECG composite score was defined as the sum of these markers (0–3). Early AF recurrence was defined as electrocardiographically documented recurrence within 10 days after ECV. Multivariable logistic regression analysis was performed. Results: Early AF recurrence occurred in 100 patients (51.3%). AF duration was longer in patients with recurrence (12 [3–57] vs. 5 [2–15] months, p < 0.001). Notched P‐wave (76.0% vs. 24.2%, p < 0.001), fQRS (74.0% vs. 57.9%, p = 0.017), and ERP (41.0% vs. 24.2%, p = 0.015) were more frequent in patients with recurrence. In multivariable analysis, notched P‐wave (OR 11.80), fQRS (OR 2.34), and ERP (OR 3.54) independently predicted recurrence (all p < 0.05). The ECG composite score was also independently associated with recurrence (OR 4.91 per 1‐point increase, p < 0.001), with a stepwise increase in recurrence across score categories. Conclusions: Simple 12‐lead ECG markers and a composite ECG score may help predict early AF recurrence and guide rhythm‐control strategies after ECV in patients with persistent AF.
- Open Access
- 3 August 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (4) , e70439
Clinical and Echocardiographic Factors Associated With AI ‐Estimated Atrial Fibrillation Likelihood During Sinus Rhythm in Patients With Documented Paroxysmal Atrial Fibrillation
Background: Artificial intelligence‐enabled electrocardiography (AI‐ECG) has emerged as a promising tool for identifying patients with atrial fibrillation (AF) using sinus‐rhythm ECGs. However, some patients with paroxysmal AF (PAF) may be assigned by AI‐ECG to lower AF likelihood categories. Clinical and echocardiographic characteristics associated with AF likelihood assignment by AI‐ECG remain unclear. Methods: This single‐center prospective study enrolled adults with documented PAF admitted for catheter ablation who were in sinus rhythm on the admission ECG. The four AF likelihood categories output by AI‐ECG were dichotomized into higher and lower groups for analysis. Logistic regression was used to assess factors associated with assignment by AI‐ECG to the higher AF likelihood group. Results: Among 104 patients, 36 were categorized into the lower and 68 into the higher AF likelihood group. Hypertension was associated with lower odds of higher‐group assignment (odds ratio [OR], 0.25; 95% confidence interval [CI], 0.10–0.66). In the echocardiographic model, higher left ventricular mass index (LVMI) was associated with lower (OR, 0.72 per 10 g/m 2 increase; 95% CI, 0.57–0.90) and mild or greater tricuspid regurgitation (TR) with higher (OR, 2.99; 95% CI, 1.14–7.87) odds of higher‐group assignment. Conclusions: A lower AF likelihood assignment by AI‐ECG was not uncommon among patients with documented PAF. Hypertension and higher LVMI were inversely associated with assignment to the higher AF likelihood group, whereas mild or greater TR showed a possible positive association. These findings suggest that AI‐ECG‐based AF likelihood assignment varies among patients with documented PAF during sinus rhythm.
- 3 August 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (4) , e70439
Open AccessClinical and Echocardiographic Factors Associated With AI ‐Estimated Atrial Fibrillation Likelihood During Sinus Rhythm in Patients With Documented Paroxysmal Atrial Fibrillation
Background: Artificial intelligence‐enabled electrocardiography (AI‐ECG) has emerged as a promising tool for identifying patients with atrial fibrillation (AF) using sinus‐rhythm ECGs. However, some patients with paroxysmal AF (PAF) may be assigned by AI‐ECG to lower AF likelihood categories. Clinical and echocardiographic characteristics associated with AF likelihood assignment by AI‐ECG remain unclear. Methods: This single‐center prospective study enrolled adults with documented PAF admitted for catheter ablation who were in sinus rhythm on the admission ECG. The four AF likelihood categories output by AI‐ECG were dichotomized into higher and lower groups for analysis. Logistic regression was used to assess factors associated with assignment by AI‐ECG to the higher AF likelihood group. Results: Among 104 patients, 36 were categorized into the lower and 68 into the higher AF likelihood group. Hypertension was associated with lower odds of higher‐group assignment (odds ratio [OR], 0.25; 95% confidence interval [CI], 0.10–0.66). In the echocardiographic model, higher left ventricular mass index (LVMI) was associated with lower (OR, 0.72 per 10 g/m 2 increase; 95% CI, 0.57–0.90) and mild or greater tricuspid regurgitation (TR) with higher (OR, 2.99; 95% CI, 1.14–7.87) odds of higher‐group assignment. Conclusions: A lower AF likelihood assignment by AI‐ECG was not uncommon among patients with documented PAF. Hypertension and higher LVMI were inversely associated with assignment to the higher AF likelihood group, whereas mild or greater TR showed a possible positive association. These findings suggest that AI‐ECG‐based AF likelihood assignment varies among patients with documented PAF during sinus rhythm.
- Open Access
- 19 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Kynurenic acid mediates epicardial fat-induced lymphatic metabolic dysfunction in atrial fibrillation
Atrial fibrillation represents a prevalent cardiac arrhythmia whose pathogenic mechanisms remain incompletely understood. Here, we identify impaired atrial lymphangiogenesis as a critical determinant in atrial fibrillation pathogenesis. Analysis of human left atrial appendage specimens reveals decreased lymphatic vessel density in atrial fibrillation patients compared to those in sinus rhythm. Mechanistically, we demonstrate that epicardial adipose tissues from atrial fibrillation patients secrete kynurenic acid, which acts via GPR35 to disrupt lymphatic endothelial cell metabolism and mitochondrial homeostasis, ultimately promoting endothelial-to-mesenchymal transition. Using an organotypic culture system, we show that epicardial adipose tissue -derived factors directly impair lymphatic vessel formation. In vivo studies utilizing angiotensin II-induced and high-fat diet male mouse models confirm the critical role of lymphatic dysfunction in atrial fibrillation susceptibility. Therapeutic interventions promoting lymphangiogenesis, either through VEGFC administration or weight loss intervention by LY3437943 (the novel triple GIP, GLP-1, and glucagon receptor agonist), significantly attenuate atrial fibrillation inducibility. These findings establish lymphatic dysfunction as a novel pathogenic mechanism in atrial fibrillation and highlight lymphatic vessel formation as a promising therapeutic target.
- 19 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessKynurenic acid mediates epicardial fat-induced lymphatic metabolic dysfunction in atrial fibrillation
Atrial fibrillation represents a prevalent cardiac arrhythmia whose pathogenic mechanisms remain incompletely understood. Here, we identify impaired atrial lymphangiogenesis as a critical determinant in atrial fibrillation pathogenesis. Analysis of human left atrial appendage specimens reveals decreased lymphatic vessel density in atrial fibrillation patients compared to those in sinus rhythm. Mechanistically, we demonstrate that epicardial adipose tissues from atrial fibrillation patients secrete kynurenic acid, which acts via GPR35 to disrupt lymphatic endothelial cell metabolism and mitochondrial homeostasis, ultimately promoting endothelial-to-mesenchymal transition. Using an organotypic culture system, we show that epicardial adipose tissue -derived factors directly impair lymphatic vessel formation. In vivo studies utilizing angiotensin II-induced and high-fat diet male mouse models confirm the critical role of lymphatic dysfunction in atrial fibrillation susceptibility. Therapeutic interventions promoting lymphangiogenesis, either through VEGFC administration or weight loss intervention by LY3437943 (the novel triple GIP, GLP-1, and glucagon receptor agonist), significantly attenuate atrial fibrillation inducibility. These findings establish lymphatic dysfunction as a novel pathogenic mechanism in atrial fibrillation and highlight lymphatic vessel formation as a promising therapeutic target.
- Open Access
Clinical Practice and Diagnostic Trends in Hereditary Transthyretin Amyloidosis: A 25-Year Observational Study
Background and Objectives: Hereditary transthyretin amyloidosis (ATTRv), a multisystemic disorder caused by transthyretin (TTR) gene mutations, exhibits phenotypic heterogeneity that can hamper recognition in non-endemic areas. Here, we investigated the clinical practice of ATTRv amyloidosis over an extended period and examined the challenges currently faced in non-endemic regions. Materials and Methods: We conducted an observational study of 18 patients with ATTRv amyloidosis diagnosed at Oita University and its affiliated hospitals between 2000 and 2025, using both retrospective and prospective data collection, to evaluate clinical features, treatments, and outcomes. Results: The median age at disease onset was 64 years, and 27.8% of patients had a family history of the disease. Val30Met (V30M) was the most common (55.6%) mutation; Tyr114Ser was the most common non-V30M variant. Sensory disturbances (50%) were the most common initial symptoms, followed by cardiac symptoms (38.9%). The cardiology department most frequently diagnosed ATTRv amyloidosis, followed by the neurology department. Two patients were relatives of previously diagnosed probands and were therefore identified during their first visit to the initial department. New diagnoses increased over time (1 in 2000–2009, 7 in 2010–2019, and 10 in 2020–2025), although diagnostic delays persisted. After the therapeutic agents shifted from patisiran to vutrisiran, the serum TTR value decreased (p = 0.0078) without significant deterioration in cardiac parameters. In the current treatment era, longer-term survivors have been observed, but multiple organ dysfunction has become more apparent, and ocular manifestations have emerged as a clinically important problem, particularly in patients with longer disease duration (p = 0.0169). Conclusions: Physicians in various departments must remain vigilant for the presence of ATTRv amyloidosis. Addressing challenges faced by long-term survivors, including ocular manifestations and central nervous system complications, has become crucial, even in non-endemic areas.
Open AccessClinical Practice and Diagnostic Trends in Hereditary Transthyretin Amyloidosis: A 25-Year Observational Study
Background and Objectives: Hereditary transthyretin amyloidosis (ATTRv), a multisystemic disorder caused by transthyretin (TTR) gene mutations, exhibits phenotypic heterogeneity that can hamper recognition in non-endemic areas. Here, we investigated the clinical practice of ATTRv amyloidosis over an extended period and examined the challenges currently faced in non-endemic regions. Materials and Methods: We conducted an observational study of 18 patients with ATTRv amyloidosis diagnosed at Oita University and its affiliated hospitals between 2000 and 2025, using both retrospective and prospective data collection, to evaluate clinical features, treatments, and outcomes. Results: The median age at disease onset was 64 years, and 27.8% of patients had a family history of the disease. Val30Met (V30M) was the most common (55.6%) mutation; Tyr114Ser was the most common non-V30M variant. Sensory disturbances (50%) were the most common initial symptoms, followed by cardiac symptoms (38.9%). The cardiology department most frequently diagnosed ATTRv amyloidosis, followed by the neurology department. Two patients were relatives of previously diagnosed probands and were therefore identified during their first visit to the initial department. New diagnoses increased over time (1 in 2000–2009, 7 in 2010–2019, and 10 in 2020–2025), although diagnostic delays persisted. After the therapeutic agents shifted from patisiran to vutrisiran, the serum TTR value decreased (p = 0.0078) without significant deterioration in cardiac parameters. In the current treatment era, longer-term survivors have been observed, but multiple organ dysfunction has become more apparent, and ocular manifestations have emerged as a clinically important problem, particularly in patients with longer disease duration (p = 0.0169). Conclusions: Physicians in various departments must remain vigilant for the presence of ATTRv amyloidosis. Addressing challenges faced by long-term survivors, including ocular manifestations and central nervous system complications, has become crucial, even in non-endemic areas.
- 18 February 2026
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 122 (5) , 554-555
Sodium–myo-inositol cotransporter-1: a missing metabolic–calcium link in pathological cardiac hypertrophy
- 18 February 2026
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 122 (5) , 554-555
Sodium–myo-inositol cotransporter-1: a missing metabolic–calcium link in pathological cardiac hypertrophy
- Open Access
- 3 February 2026
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 13 (1)
Controlling Nutritional Status score as a predictor of ventricular arrhythmias in patients with advanced heart failure
Malnutrition is common among heart failure (HF) patients and may affect prognosis. Its effects on arrhythmia outcomes in HF patients remain unclear. We evaluated whether malnutrition, as assessed using the Controlling Nutritional Status (CONUT) score and Geriatric Nutritional Risk Index (GNRI), predicts ventricular arrhythmias and all-cause mortality in advanced HF patients receiving cardiac resynchronization therapy (CRT). This retrospective single-centre cohort study enrolled 167 patients (mean age 70.9 ± 9.5 years, 67.1% male) who underwent CRT between March 2004 and February 2023. Nutritional status was assessed using the CONUT score and GNRI before CRT. Malnutrition was defined as a CONUT score ≥5 and a GNRI score κ = 0.44). Kaplan–Meier survival analysis demonstrated significantly higher event rates in patients with CONUT-defined malnutrition for the primary outcome (log-rank P = .0003). Conversely, GNRI-defined malnutrition exhibited only a weak trend (log-rank P = .06). When examined separately, both nutritional indices predicted all-cause mortality (CONUT: P = .0001; GNRI: P = .01), whereas only CONUT-defined malnutrition significantly predicted ventricular arrhythmias (CONUT: P = .01; GNRI: P = .38). The multivariate Cox regression analysis confirmed CONUT-defined malnutrition as an independent predictor of the primary outcome (adjusted HR: 2.33, 95% CI: 1.30–4.20, P < .01). Adding the CONUT score to the base model significantly improved discrimination (concordance index: 0.695 to 0.713, P = .008). Time-dependent receiver operating characteristic analysis showed an AUC of 0.80 (95% CI: 0.67–0.94) at 1825 days for CONUT-defined malnutrition. CONUT-defined malnutrition was a strong independent predictor of ventricular arrhythmias and all-cause mortality in CRT recipients. Nutritional assessment may enhance risk stratification in patients with advanced HF undergoing CRT.
- 3 February 2026
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 13 (1)
Open AccessControlling Nutritional Status score as a predictor of ventricular arrhythmias in patients with advanced heart failure
Malnutrition is common among heart failure (HF) patients and may affect prognosis. Its effects on arrhythmia outcomes in HF patients remain unclear. We evaluated whether malnutrition, as assessed using the Controlling Nutritional Status (CONUT) score and Geriatric Nutritional Risk Index (GNRI), predicts ventricular arrhythmias and all-cause mortality in advanced HF patients receiving cardiac resynchronization therapy (CRT). This retrospective single-centre cohort study enrolled 167 patients (mean age 70.9 ± 9.5 years, 67.1% male) who underwent CRT between March 2004 and February 2023. Nutritional status was assessed using the CONUT score and GNRI before CRT. Malnutrition was defined as a CONUT score ≥5 and a GNRI score κ = 0.44). Kaplan–Meier survival analysis demonstrated significantly higher event rates in patients with CONUT-defined malnutrition for the primary outcome (log-rank P = .0003). Conversely, GNRI-defined malnutrition exhibited only a weak trend (log-rank P = .06). When examined separately, both nutritional indices predicted all-cause mortality (CONUT: P = .0001; GNRI: P = .01), whereas only CONUT-defined malnutrition significantly predicted ventricular arrhythmias (CONUT: P = .01; GNRI: P = .38). The multivariate Cox regression analysis confirmed CONUT-defined malnutrition as an independent predictor of the primary outcome (adjusted HR: 2.33, 95% CI: 1.30–4.20, P < .01). Adding the CONUT score to the base model significantly improved discrimination (concordance index: 0.695 to 0.713, P = .008). Time-dependent receiver operating characteristic analysis showed an AUC of 0.80 (95% CI: 0.67–0.94) at 1825 days for CONUT-defined malnutrition. CONUT-defined malnutrition was a strong independent predictor of ventricular arrhythmias and all-cause mortality in CRT recipients. Nutritional assessment may enhance risk stratification in patients with advanced HF undergoing CRT.
- Open Access
- 2 December 2025
- Published by Springer Nature in Research Square
Factors associated with achieving the 10-minute scene-to-ECG transmission target in prehospital care: the role of EMS agency-level cumulative ECG transmissions
Background Prehospital 12-lead electrocardiogram (ECG) improves outcomes in ST-segment elevation myocardial infarction, yet meeting the 10-minute target from first medical contact remains difficult. We evaluated determinants of faster prehospital ECG performance. Methods We analysed a prefecture-wide registry in Japan (September 2021 to August 2025) of patients with suspected acute coronary syndrome who had prehospital ECG transmission. Prehospital ECG performance was assessed using the scene-to-ECG interval, from emergency medical services (EMS) on-scene arrival to ECG transmission. The primary outcome was scene-to-ECG ≤ 10 minutes; the secondary outcome was interval length. Agency experience was measured by cumulative ECG transmissions. Mixed-effects logistic and linear models with agency random intercepts adjusted for age, sex, and time of arrival, and included calendar-period indicators and a period-by-experience interaction. Results Of 1,748 patients, 672 (38.4%) achieved ≤ 10 minutes; the median scene-to-ECG was 12 minutes (interquartile range 9 to 17). Greater cumulative transmissions were associated with higher odds of ≤ 10 minutes (adjusted odds ratio 1.07 per 100 cases, 95% confidence interval 1.02 to 1.14) and shorter intervals (β − 0.29 minutes per 100 cases, 95% confidence interval − 0.39 to − 0.19) but were not statistically significant after adding period and the interaction. Older age, female sex, and nighttime arrival were associated with longer intervals. Conclusions At the EMS agency level, higher cumulative ECG transmissions were associated with achieving the ≤ 10-minute scene-to-ECG target. This suggests that focused onboarding and continued EMS training may enhance prehospital ECG performance. Older age, female sex, and night-time arrival were associated with not achieving the target.
- 2 December 2025
- Published by Springer Nature in Research Square
Open AccessFactors associated with achieving the 10-minute scene-to-ECG transmission target in prehospital care: the role of EMS agency-level cumulative ECG transmissions
Background Prehospital 12-lead electrocardiogram (ECG) improves outcomes in ST-segment elevation myocardial infarction, yet meeting the 10-minute target from first medical contact remains difficult. We evaluated determinants of faster prehospital ECG performance. Methods We analysed a prefecture-wide registry in Japan (September 2021 to August 2025) of patients with suspected acute coronary syndrome who had prehospital ECG transmission. Prehospital ECG performance was assessed using the scene-to-ECG interval, from emergency medical services (EMS) on-scene arrival to ECG transmission. The primary outcome was scene-to-ECG ≤ 10 minutes; the secondary outcome was interval length. Agency experience was measured by cumulative ECG transmissions. Mixed-effects logistic and linear models with agency random intercepts adjusted for age, sex, and time of arrival, and included calendar-period indicators and a period-by-experience interaction. Results Of 1,748 patients, 672 (38.4%) achieved ≤ 10 minutes; the median scene-to-ECG was 12 minutes (interquartile range 9 to 17). Greater cumulative transmissions were associated with higher odds of ≤ 10 minutes (adjusted odds ratio 1.07 per 100 cases, 95% confidence interval 1.02 to 1.14) and shorter intervals (β − 0.29 minutes per 100 cases, 95% confidence interval − 0.39 to − 0.19) but were not statistically significant after adding period and the interaction. Older age, female sex, and nighttime arrival were associated with longer intervals. Conclusions At the EMS agency level, higher cumulative ECG transmissions were associated with achieving the ≤ 10-minute scene-to-ECG target. This suggests that focused onboarding and continued EMS training may enhance prehospital ECG performance. Older age, female sex, and night-time arrival were associated with not achieving the target.